EVANGELISTA, LAURA
 Distribuzione geografica
Continente #
AS - Asia 7.339
NA - Nord America 6.145
SA - Sud America 1.429
EU - Europa 1.154
Continente sconosciuto - Info sul continente non disponibili 418
AF - Africa 149
OC - Oceania 20
Totale 16.654
Nazione #
US - Stati Uniti d'America 5.926
SG - Singapore 5.022
BR - Brasile 1.180
CN - Cina 984
VN - Vietnam 652
IT - Italia 356
DE - Germania 344
HK - Hong Kong 144
IN - India 109
CA - Canada 95
AR - Argentina 89
BD - Bangladesh 80
GB - Regno Unito 77
MX - Messico 68
RU - Federazione Russa 50
EC - Ecuador 48
IQ - Iraq 46
ZA - Sudafrica 43
FR - Francia 38
PL - Polonia 38
TR - Turchia 38
NL - Olanda 33
CO - Colombia 28
ES - Italia 27
ID - Indonesia 26
VE - Venezuela 26
MA - Marocco 25
UA - Ucraina 25
SA - Arabia Saudita 23
AT - Austria 22
PH - Filippine 20
AE - Emirati Arabi Uniti 19
IE - Irlanda 19
SE - Svezia 19
JP - Giappone 18
PK - Pakistan 18
CL - Cile 17
FI - Finlandia 17
KE - Kenya 17
CZ - Repubblica Ceca 16
AU - Australia 13
AZ - Azerbaigian 13
UZ - Uzbekistan 13
IL - Israele 12
MY - Malesia 12
PE - Perù 12
PY - Paraguay 12
TN - Tunisia 12
AL - Albania 11
NG - Nigeria 11
EG - Egitto 10
LT - Lituania 10
NP - Nepal 10
BO - Bolivia 9
DZ - Algeria 9
HN - Honduras 8
JM - Giamaica 8
JO - Giordania 8
OM - Oman 8
KG - Kirghizistan 7
DO - Repubblica Dominicana 6
GT - Guatemala 6
KW - Kuwait 6
KZ - Kazakistan 6
LV - Lettonia 6
PT - Portogallo 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
UY - Uruguay 6
CR - Costa Rica 5
GR - Grecia 5
IR - Iran 5
NI - Nicaragua 5
SY - Repubblica araba siriana 5
DK - Danimarca 4
ET - Etiopia 4
GA - Gabon 4
SN - Senegal 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BE - Belgio 3
BG - Bulgaria 3
BW - Botswana 3
BY - Bielorussia 3
GE - Georgia 3
KH - Cambogia 3
KR - Corea 3
LB - Libano 3
NO - Norvegia 3
NR - Nauru 3
PS - Palestinian Territory 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BH - Bahrain 2
BS - Bahamas 2
DM - Dominica 2
GY - Guiana 2
Totale 16.206
Città #
Singapore 2.114
San Jose 1.295
Ashburn 1.134
Dallas 879
The Dalles 822
Shanghai 415
Falkenstein 224
Beijing 216
Ho Chi Minh City 214
Hanoi 144
Hong Kong 133
Milan 114
Los Angeles 112
São Paulo 111
Santa Clara 99
New York 77
Seattle 69
Rome 55
Boardman 42
Council Bluffs 42
Da Nang 36
Buffalo 35
Brooklyn 34
Montreal 31
Warsaw 31
Assago 30
Chandler 29
Chennai 29
Haiphong 29
Orem 29
Curitiba 27
Munich 27
Rio de Janeiro 27
Chicago 26
Wilmington 25
Brasília 23
Boston 22
Toronto 22
Belo Horizonte 21
Dhaka 20
Guayaquil 20
Johannesburg 19
Mexico City 19
Dublin 18
Atlanta 17
Baghdad 17
Campinas 17
Goiânia 17
Phoenix 17
Stockholm 17
Figino 16
Helsinki 16
Quito 16
Buenos Aires 15
Charlotte 15
Tokyo 15
Philadelphia 14
San Mateo 14
Amsterdam 13
Ann Arbor 13
London 13
Nairobi 13
Baku 12
Biên Hòa 12
Denver 12
Frankfurt am Main 12
Porto Alegre 12
Salvador 12
San Francisco 12
Bắc Ninh 11
Cape Town 11
Guarulhos 11
Houston 11
Naples 11
Ribeirão Preto 11
Ankara 10
Brno 10
Dubai 10
Düsseldorf 10
Fortaleza 10
Hangzhou 10
Istanbul 10
New Delhi 10
Reston 10
Santo André 10
Tashkent 10
Vienna 10
Bắc Giang 9
Jeddah 9
Lima 9
Nuremberg 9
Riyadh 9
Caxias do Sul 8
Hải Dương 8
Manila 8
Montes Claros 8
Santiago 8
Sumaré 8
Thái Nguyên 8
Agadir 7
Totale 9.593
Nome #
10-Year Clinical Experience with 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 Patients 630
PET-CT radiomics for immunotherapy response 170
18F-fluorodeoxyglucose PET/computed tomography and risk stratification after neoadjuvant treatment in esophageal cancer patients 121
BNCT treatment: 18F-FBPA PET-CT 112
A prospective trial for the evaluation of esophageal cancer patients: FDG PET/CT vs. c.e.CT vs. FDG PET/c.e.CT 102
Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer 88
Development and evaluation of a bayesian optimization FDG population-based input function for implementing parametric imaging in the clinical practice 83
Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team 83
18F-FET PET/CT in Calcifying Pseudoneoplasm of the Neuraxis: First Case 81
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review—Part 1 oncological setting 80
New target therapies in prostate cancer: from radioligand therapy, to PARP-inhibitors and immunotherapy 80
SEGMENTAL FDG-PET/CT IN SOLITARY PULMONARY NODULE: PRELIMINARY DATA OF THE PET ITALIAN TRIAL 80
An incidental pancreatic finding at 18F-choline PET/CT: Chronic mass-forming pancreatitis 79
Emerging Radiopharmaceuticals in Pet Imaging for Mesothelioma: A Review of [18F]FDG Alternatives 77
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 75
Summary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16α-[18F]Fluoro-17β-Estradiol PET 71
Diagnostic and prognostic value of gated myocardial perfusion single-photon emission computed tomography in low-risk patients with left bundle-branch block 66
18F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature 66
Advancing Prostate Cancer Care: Prostate-specific Membrane Antigen–based Radioligand Therapy at the Forefront 65
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 65
Comparison between conventional imaging (CI) and wholebody 18F-choline (FCH) positron emission tomography/ computed tomography (PET/CT) in patients (pts) with prostate cancer (PCa) 64
An Evaluation of the Diagnostic Accuracy of [68Ga]Ga-PSMA-11 vs. [18F]F-PSMA-1007 PET/CT for Lymph Node Staging in Patient Candidates for Radical Prostatectomy and Lymph Node Dissection: A Single Institutional Analysis 64
PET/MR in recurrent glioblastoma patients treated with regorafenib: [18F]FET and DWI-ADC for response assessment and survival prediction 63
18F-DOPA and 18F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: two case reports 61
Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study 60
18F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant Chemotherapy 59
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach 58
18F-Facbc in Prostate Cancer: A Systematic Review and Meta-Analysis 58
Relazione tra ischemia miocardica inducibile e livelli plasmatici di proteina C reattiva in pazienti con sospetta cardiopatia ischemica 58
18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy 57
18F-Fluoroestradiol Positron Emission Tomography In Breast Cancer Patients: Systematic Review Of The Literature &; Meta-Analysis 57
MUNES: a MUltidisciplinar Neutron Source for BNCT and Nuclear Waste characterization 57
Positron emission tomography/computed tomography and esophageal cancer in the clinical practice: How does it affect the prognosis? 56
An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastases 56
18F-Choline PET/CT: An Alternative Tracer for Hodgkin Lymphoma? 55
18F-choline PET/CT in prostate cancer for the staging, the restaging and planning radiotherapy treatment 55
Diagnosi e stadiazione del cancro della mammella Il Medico Nucleare: stato dell’arte e risposta ai punti controversi 54
L’imaging funzionale nelle disautonomie 54
Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer 54
18F-Choline: Prostate Cancer18F-choline PET/CT: an increasing role in cancer evaluation 54
The role of 18f-fdg pet/ct in staging and prognostication of mantle cell lymphoma: An italian multicentric study 53
ENDOCRINE ORGANS INVOLVEMENT IN BREAST CANCER: WHEN THE TEAMWORK MAKES THE DIFFERENCE 53
18F-Choline PET/CT and prostatic gland/fossae recurrence: what can help to identify the local recurrence of disease? 53
18F-DOPA PET/CT in different neuroendocrine settings: staging, restaging and increase in tumor markers 53
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review– part 2 52
PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature 52
18 F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases 52
Comparison of prognostic value of baseline and nitrate Single-photon Emission computed tomography imaging in patients with ischaemic left ventricular dysfunction 52
Prostate MRI and PSMA-PET in the Primary Diagnosis of Prostate Cancer 52
[18F]FDG and Lymphomas: Still a Winning Golden Couple in the Era of FAPI-Based Radiotracers 51
Clinical Application of PET/MRI 51
18F-FDG or 68Ga/18F-PSMA PET/CT in recurrent renal cancer? 51
Copper, PeT/cT and prostate cancer: A systematic review of the literature 50
18F-FDG PET/CT in gynecologic malignancies: single Institution experience 50
The evolution of PET imaging in renal, bladder, upper urinary tract urothelial, testicular and penile carcinoma – Today’s impact, tomorrow’s potential 50
The ability of 18F-choline PET/CT to identify local recurrence of prostate cancer 49
Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patients 49
Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study 49
Additional value of PET and CT image-based features in the detection of occult lymph node metastasis in lung cancer: a systematic review from the literature 48
18F-FDG PET/MRI in adult sarcomas 48
18F-Fluoroestradiol positron emission tomography in breast cancer patients: systematic review of the literature & meta-analysis 48
Lymphoid organs’ metabolism and its role in predicting the outcomes of patients with malignant melanoma treated with immunotherapy: an exploratory study 48
Head-to-Head Comparison between Peptide-Based Radiopharmaceutical for PET and SPECT in the Evaluation of Neuroendocrine Tumors: A Systematic Review 47
Head-to-head comparison between 18F-FDG PET/CT and PET/MRI in breast cancer 47
From Bottleneck to Enabler: A New Approach to Regulating Data-Driven Medical Research 47
The effects of androgen deprivation therapy on the 18F-choline uptake in prostate cancer patients undergoing neoadjuvant treatment 47
Somatostatin Receptor PET/CT Imaging for the Detection and Staging of Pancreatic NET: A Systematic Review and Meta-Analysis 46
Il radiologo e il medico nucleare: nodulo/i polmonare/i 46
Clinical Impact of 18F-FDG PET/CT in the Diagnostic Workup of Pancreatic Ductal Adenocarcinoma: A Systematic Review 46
Relation between stress-induced myocardial ischemia and C- reactive protein levels in patients with suspected coronary arteery disease 46
Indeterminate pulmonary nodules on CT images in breast cancer patient: The additional value of 18F-FDG PET/CT 46
Ruolo della Tomografia ad emissione di fotone singolo nella definizione della probabilità di cardiopatia ischemica nei pazienti diabetici: risultati di un trial multi prospettico, multicentrico 45
Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art 45
Usefullness of stress cardiac single photon emission computesd tomography iomaging late after percutaneous coronary intervention for assessing cardiac events and time to such events 45
Incidental Detection of Sarcomatoid Lung Cancer by [18F] Choline Positron Emission Tomography/Computed Tomography 45
PET-guided prognosis: a promising role of metabolic imaging in esophageal cancer. 45
An Incidental Uptake of 18F-Choline at PET/CT in Gastric Neuroendocrine Tumor 45
[18F]FDG PET/CT and PET/MR in Patients with Adrenal Lymphoma: A Systematic Review of Literature and a Collection of Cases 45
18F-FDG PET/CT in ovarian cancer 45
FDG PET/CT Volume-Based Quantitative Data and Survival Analysis in Breast Cancer Patients: A Systematic Review of the Literature 45
Boron neutron capture therapy and 18F-labelled borophenylalanine positron emission tomography: a critical and clinical overview of the literature 44
Comparison between18F-Dopa and 18F-Fet PET/CT in patients with suspicious recurrent high grade glioma: A literature review and our experience 44
An incidental finding behind adrenal incidentaloma 44
The performance of FDG PET/CT in single pulmonary nodules (SPNs): preliminary analysis from The Italian Tailored Assessment of Lung Indeterminate Accidental Nodule (ITALIAN) multicentre trial 43
Metastasi ossee: scintigrafia ossea e PET 43
Ruolo della PET/scintigrafia ossea? 43
PET/CT And The Response To Immunotherapy In Lung Cancer 43
The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's Health 43
Ga-68 DOTA-peptides and F-18 FDG PET/CT in patients with neuroendocrine tumor: A review 43
The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation 43
Interpretative reproducibility of cardiac stress imaging: direct comparison between dobutamine echocardiography and single photon emission computed tomography 43
Therapeutic impact of (18)F-FDG PET/CT in recurrent differentiated thyroid carcinoma 42
Additional value of pet radiomic features for the initial staging of prostate cancer: A systematic review from the literature 42
Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE 42
EARLY AND LATE IMAGES OF 18F-CHOLINE (FCH) PET/CT FOR THE DETECTION OF PROSTATIC FOSSAE RECURRENCES IN PROSTATE CANCER WITH A BIOCHEMICAL FAILURE (PSA< 2 NG/ML) 42
A false-positive finding in 18F-FDG PET/CT images in patients with right Malignant Pleural Mesothelioma (MPM) after extrapleural pneumonectomy 42
Role of FDG-PET/CT in the staging of colonrectal cancer 42
Molecular imaging of PARP in cancer: state-of-the-art 42
Risk stratification and prognostic assessment by myocardial perfusion-gated SPECT in patients with left bundle-branch block and low-intermediate cardiac risk 42
Accuracy of 18F-FDG PET/CT versus bone marrow biopsy in assessing bone marrow involvement in paediatric Hodgkin's Lymphoma. Accuracy in a multicenter series of 156 patients 42
Totale 6.219
Categoria #
all - tutte 98.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.274


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202228 0 0 1 8 1 2 1 1 4 2 6 2
2022/202375 12 5 8 12 3 5 0 3 14 5 8 0
2023/20241.081 2 5 9 4 1 10 3 4 357 59 272 355
2024/20254.266 114 153 19 74 52 500 216 204 846 1.102 475 511
2025/202610.757 1.579 671 862 808 411 603 3.346 665 464 639 280 429
2026/2027391 330 61 0 0 0 0 0 0 0 0 0 0
Totale 16.654